[Course, therapy and diagnostic problems in diabetics with lactacidosis after biguanide treatment].
D001645:Biguanides / Q000009:adverse effects* / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced* / Q000188:drug therapy; D004298:Dopamine / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007773:Lactates / Q000097:blood
D001645:Biguanides; D007328:Insulin; D007773:Lactates; D005665:Furosemide; D005947:Glucose; D004298:Dopamine
Verlauf, Therapie und diagnostische Probleme bei Diabetikern mit Laktazidose nach Biguanidbehandlung.